Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 1-6

  Adams, Volker ^a,d   Schmid, Stephan ^a   Zariwala, Maimoona ^b,e   Schmid, Mirka ^a   Kleihues, Paul ^b,f   Briner, Jakob ^a   Schäfer, Reinhold ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Mutational analysis; Nested PCR; Restriction analysis; Single strand conformation polymorphism

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE MUTATION; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WART VIRUS;

DNA, VIRAL; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MUTATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION;

EID: 0032921640     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gorsky M, Dayan D, Marom Z, and Silverman SJ: Consumption of tobacco as an etiological factor in a group of 465 oral cancer patients in Israel. Cancer J 5: 208-210, 1992.
2. Schottenfeld D: The etiology and prevention of aerodigestive tract cancers. Newell GR and Hong WK. The biology and prevention of aerodigestive tract cancers. New York, Plenum Press, 1992.
3. Brachman DG: Molecular biology of head and neck cancer. Semin Oncol 21: 320-329, 1994.
4. Carey TE: Genetic Mechanisms in the development and progression of head and neck cancer. Curr Opp Otolaryng Head and Neck Surg 3: 75-83, 1995.
5. Levine AJ, Momand J, and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
6. Lane DP: p53. Guardian of the Genome. Nature 358: 15-16, 1992.
7. Snijders PJF, Van den Brule AJC, Meijer CJLM, and Walboomers JMM: Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Top Microbiol Immunol 186: 177-198, 1994.
8. Zur Hausen H: Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Canc Res 49: 4677-4681, 1989.
9. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.
10. Werness BA, Levine AJ, and Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
11. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, and Laimins LA: Human Papillomavirus E6 Proteins Bind p53 In vivo and Abrogate p53-Mediated Repression of Transcription. EMBO J 11: 3045-3052, 1992.
12. Rolfe M, Beer-Romero P, Glass S, Eckstein J, Berdo I, Pagano M, and Draetta G: Reconstitution of p53-ubiquitinylation reactions from purified components: The role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). Proc Natl Acad Sci USA 92: 3264-3268, 1995.
13. Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, and Weichselbaum RR: occurrence of p53 Gene Deletions and Human Papilloma Virus Infection in Human Head and Neck Cancer. Cancer Res 52: 4832-4836, 1992.
14. Suzuki T, Shidara K, Hara F, and Nakajima T: High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection. Jpn J Cancer Res 85: 1087-1093, 1994.
15. Fouret P, Dabit D, Sibony M, Alili D, Commo F, Stguily JL, and Callard P: Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol 146: 599-604, 1995.
16. Snijders PJF, Steenbergen RDM, Top B, Scott SD, Meijer CJ, and Walboomers JMM: Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 75: 2769-2775, 1994.
17. Snijders PJ, Cromme FV, van-den-Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, and Walboomers JM: Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 51: 845-850, 1992.
18. Hoshikawa T, Nakajima T, Uhara H, Gotoh M, Shimosato Y, Tsutsumi K, Ono I, and Ebihara S: Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction. Laryngoscope 100: 647-650, 1990.
19. Crook T, Wrede D, and Vousden KH: p53 point mutations in HPV negative human cervical carcinoma cell lines. Oncogene 6: 873-875, 1991.
20. Lee YY, Wilczynski S, Chumakov A, Chih D, and Koeffler P: Carcinoma of the vulva: HPV and p53 mutations. Oncogene 9: 1655-1659, 1994.
21. Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C, and Kittas C: Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: Possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Archiv 425: 481-489, 1994.
22. Scholes AG, Liloglou T, Snijders PJ, Hart CA, Jones AS, Woolgar JA, Vaughan ED, Walboomers JM, and Field JK: p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer 71: 796-799, 1997.
23. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, Notani K, and Fukuda H: Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 12: 1663-1668, 1996.
24. Zariwala M, Schmid S, Pfaltz M, Ohgaki H, Kleihues P, and Schäfer R: p53 gene mutations in oropharyngeal carcinomas: A comparison of solitary and multiple primary tumors and lymph node metastases. Int J Cancer 56: 807-811, 1994.
25. Ting X, Manos and EM Detection and typing of genital human papillomaviruses. In: Innes MA, Gelfand DH and Sninsky JJ (eds.) PCR protocols: A guide to methods and applications, New York, Academic Press, 356-367, 1990.
26. Adams V, Kempf W, Hassam S, Briner J, Schmid M, Moos R, and Pfaltz M: Detection of several types of human papilloma viruses in Aids-associated Kaposi's sarcoma. J Med Virol 46: 189-193, 1995.
27. Adams V, Moll C, Schmid M, Rodrigues C, Moos R, and Briner J: Detection and typing of human papillomavirus in biopsy and cytological specimens by PCR and restriction enzyme analysis. J Med Virol 48: 161-170, 1996.
28. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, and Dalla-Favera R: P53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88: 5413-5417, 1991.
29. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smithsorensen B, Montesano R, and Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994.
30. Slaughter DP, Southwick HW, and Smejkal W: "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6: 963-968, 1953.
31. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, and Roth JA: Discordant p53 Gene Mutations in Primary Head and Neck Cancers and Corresponding Second Primary Cancers of the Upper Aerodigestive Tract. Cancer Res 53: 1676-1683, 1993.
32. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, De Gregorio L, Maneti G, Radice P, Minoletti F, Della Porta G, and Pierotti MA: Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Canc Res 55: 135-140, 1995.
33. Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, and Hittelman WN: Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Canc Res 53: 2874-2883, 1993.
34. Grandis JR and Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Canc Res 53: 3579-3584, 1993.
35. Shin DM, Ro JY, Hong WK, and Hittelman WN: Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cane Res 54: 3153-3159, 1994.
36. Momand J, Zambetti GP, Olson DC, George D, and Levine AJ: The mdm-2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation. Cell 69: 1237-1245, 1992.
37. Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M, and Ishizaki K: P53 mutation, murine double minute 2 amplification, and human papilloma virus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clinical Cancer Research 1: 769-773, 1995.